ABVC BioPharma Inc [NASDAQ: ABVC] gained 29.81% on the last trading session, reaching $1.35 price per share at the time. If compared to the average trading volume of 737.10K shares, ABVC reached a trading volume of 7495322 in the most recent trading day, which is
ABVC BioPharma Inc [NASDAQ: ABVC] slipped around -0.04 points on Wednesday, while shares priced at $1.14 at the close of the session, down -3.39%. The company report on April 10, 2024 at 8:30 AM that ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology
ABVC BioPharma Inc [NASDAQ: ABVC] traded at a high on Tuesday, posting a 21.90 gain after which it closed the day’ session at $1.28. The company report on March 26, 2024 at 8:30 AM that ABVC BioPharma Entered into a Global Licensing Deal of Vitargus
ABVC BioPharma Inc [NASDAQ: ABVC] closed the trading session at $1.27. The company report on February 15, 2024 at 8:30 AM that ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues. ABVC agrees to grant
© 2024, Powered by Smart TechOne
